[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Investigation Report on China's Omeprazole Market, 2018-2022

October 2018 | 30 pages | ID: I81FDFFB002EN
China Research and Intelligence Co., Ltd.

US$ 2,200.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Description

Gastric ulcer is a common disease worldwide. It is estimated that there are 25 million to 70 million gastric ulcer patients in China.

As early as the 1980s, the global market size of gastric ulcer drugs exceeded USD 8 billion. In 1988, Swedish company Astra (now known as AstraZeneca) developed a new anti-ulcer drug — proton pump inhibitor Omeprazole (trade name: Losec). Omeprazole, able to inhibit gastric acid secretion and relieve gastralgia, gastrectasia and other symptoms in a short period of time, became popular among ulcer patients immediately after it was marketed. At the end of the 20th century, the annual sales value of Omeprazole once hit a record high of USD 6.26 billion.

Chinese pharmaceutical companies began to imitate Omeprazole API in 1992, after which a large number of generic drugs were put on the market. With the launch of generic Omeprazole in China, Chinese pharmaceutical companies keep scrambling for market share from AstraZeneca. Overall, the market size of Omeprazole in China is growing, with the sales value exceeding CNY 1.3 billion in 2017. Although there are many anti-ulcer drugs on the market, because of good effects, Omeprazole stands out from its many competitors and secures its leading role. As the lifestyle changes, the number of patients with gastric ulcer continues to rise in China. In the next few years, Omeprazole will still have certain growth potential in China.

Topics Covered:
  • Situation of gastric ulcer in China
  • Sales of Omeprazole in China
  • Competition on China's Omeprazole market
  • Major Omeprazole manufacturers in China
  • Prices of Omeprazole in China
  • Prospect of China's Omeprazole market from 2018 to 2022
1 RELEVANT CONCEPTS OF OMEPRAZOLE

1.1 Indications for Omeprazole
1.2 Development of Omeprazole in China
1.3 Governmental Approval of Omeprazole in China

2 SALES OF OMEPRAZOLE IN CHINA, 2013-2017

2.1 Sales Value of Omeprazole
  2.1.1 Overall Sales Value
  2.1.2 Sales Value by Region
2.2 Sales Volume of Omeprazole
  2.2.1 Overall Sales Volume
  2.2.2 Sales Volume by Region
2.3 Sales of Omeprazole by Dosage Form in China, 2013-2017
  2.3.1 Tablets
  2.3.2 Capsules
  2.3.3 Injections

3 ANALYSIS ON MAJOR OMEPRAZOLE MANUFACTURERS IN CHINA, 2013-2017

3.1 Analysis on Market Share of Major Omeprazole Manufacturers
  3.1.1 Market Share by Sales Value
  3.1.2 Market Share by Sales Volume
3.2 Jiangsu Aosaikang Pharmaceutical Co., Ltd.
  3.2.1 Enterprise Profile
  3.2.2 Sales of Jiangsu Aosaikang Pharmaceutical Co., Ltd.'s Omeprazole in China
3.3 AstraZeneca
  3.3.1 Enterprise Profile
  3.3.2 Sales of AstraZeneca's Omeprazole in China
3.4 Changzhou Siyao Pharmaceuticals Co., Ltd.
  3.4.1 Enterprise Profile
  3.4.2 Sales of Changzhou Siyao Pharmaceuticals Co., Ltd.'s Omeprazole in China
3.5 Zhejiang Jinhua CONBA Bio-pharm. Co., Ltd.
  3.5.1 Enterprise Profile
  3.5.2 Sales of Zhejiang Jinhua CONBA Bio-pharm. Co., Ltd.'s Omeprazole in China
3.6 Hainan Lionco Pharmaceutical Co., Ltd.

4 PRICES OF OMEPRAZOLE IN CHINA, 2017-2018

4.1 Jiangsu Aosaikang Pharmaceutical Co., Ltd. (Aoyiming)
4.2 AstraZeneca (Losec)
4.3 Changzhou Siyao Pharmaceuticals Co., Ltd. (Aoke)
4.4 Zhejiang Jinhua CONBA Bio-pharm. Co., Ltd. (KIN-KONG)
4.5 Hainan Lionco Pharmaceutical Co., Ltd. (Ruiboqi)

5 PROSPECT OF CHINA'S OMEPRAZOLE MARKET, 2018-2022

5.1 Forecast on Market Size
5.2 Forecast on Market Trend

SELECTED CHARTS

Chart Sales of Omeprazole in China, 2013-2017
Chart Sales Value of Omeprazole in Parts of China, 2013-2017
Chart Sales Volume of Omeprazole in China, 2013-2017
Chart Sales Volume of Omeprazole in Parts of China, 2013-2017
Chart Sales Value of Omeprazole Tablets in China, 2013-2017
Chart Sales Volume of Omeprazole Tablets in China, 2013-2017
Chart Sales Value of Omeprazole Capsules in China, 2013-2017
Chart Sales Volume of Omeprazole Capsules in China, 2013-2017
Chart Sales Value of Omeprazole Injections in China, 2013-2017
Chart Sales Volume of Omeprazole Injections in China, 2013-2017
Chart Market Share of Top 5 Omeprazole Manufacturers by Sales Value in China, 2013-2017
Chart Market Share of Top 5 Omeprazole Manufacturers by Sales Volume in China, 2013-2017
Chart Sales Value of Jiangsu Aosaikang Pharmaceutical Co., Ltd.'s Omeprazole, 2013-2017
Chart Sales Volume of Jiangsu Aosaikang Pharmaceutical Co., Ltd.'s Omeprazole, 2013-2017
Chart Sales Value of AstraZeneca's Omeprazole, 2013-2017
Chart Sales Volume of AstraZeneca's Omeprazole, 2013-2017
Chart Prices of Jiangsu Aosaikang Pharmaceutical Co., Ltd.'s Omeprazole in Parts of China in 2017
Chart Prices of AstraZeneca's Omeprazole in Parts of China in 2017
Chart Prices of Changzhou Siyao Pharmaceuticals Co., Ltd.'s Omeprazole in Parts of China in 2017
Chart Forecast on Sales Value of Omeprazole in China, 2018-2022


More Publications